A Non-Canonical Role of SMAD4 in Regulating 3D Genome Architecture to Inhibit Lung Squamous Cell Carcinoma

Qian Tang1,2, Chen Lian1, Xinyan Han1,2

  • 1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, and Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Haining, China.

Insights

SMAD4 loss in lung squamous cell carcinoma (LUSC) disrupts 3D genome organization, activating SOX2 and promoting tumor growth. This reveals a new therapeutic target for LUSC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Lung squamous cell carcinoma (LUSC) lacks defined drivers and targeted therapies.
  • Understanding LUSC molecular pathogenesis is incomplete.

Purpose of the Study:

  • Identify key regulators of LUSC 3D genome organization.
  • Elucidate the link between tumor suppressor loss and oncogenic transcriptional activation in LUSC.

Main Methods:

  • Integrated clinical datasets, genetically engineered mouse models, and LUSC cell lines.
  • Performed multi-omics analyses to study genome organization and gene regulation.
  • Investigated the role of SMAD4 and EP300 in enhancer-promoter looping at the SOX2 locus.

Main Results:

  • SMAD4 deficiency promotes LUSC progression by enabling EP300-mediated enhancer-promoter looping at the SOX2 locus.
  • SMAD4 constrains chromatin looping by sequestering EP300, and its loss leads to aberrant SOX2 activation.
  • SMAD4 loss increases H3K27ac deposition and LUSC tumor cell proliferation.

Conclusions:

  • SMAD4 is a critical regulator of 3D genome organization in LUSC.
  • SMAD4 loss drives LUSC through dysregulated 3D genome architecture and SOX2 activation.
  • Targeting SMAD4 or its downstream effects presents a potential therapeutic strategy for LUSC.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...